收藏切换
Comparison of platelet inhibitory effect, clinical efficacy and safety of clopidogrel and ticagrelor in patients with acute coronary syndrome undergoing stent implantation
收藏切换
Qian WANG1, Ying CHEN2, Junli ZUO1, Yi QIAN2, *
World Clinical Drug | 2022, 43(3) : 253 - 258
Less
收藏切换
World Clinical Drug | 2022, 43(3): 253-258
• Article •
Comparison of platelet inhibitory effect, clinical efficacy and safety of clopidogrel and ticagrelor in patients with acute coronary syndrome undergoing stent implantation
Full
Qian WANG1, Ying CHEN2, Junli ZUO1, Yi QIAN2, *
Affiliations
  • 1.Department of Geriatrics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 201801, China
  • 2.Department of Vascular and Cardiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 201801, China
Published: 2022-03-10 doi: 10.13683/j.wph.2022.03.008
Outline
收藏切换
Objective

In order to compare the effectiveness of clopidogrel and ticagrelor in platelet ihibition in patients with acute coronary syndrome (ACS) undergoing stent implantation, and to evaluate the clinical benefits and risks.

Methods

Two hundred patients with ACS undergoing stent implantation from June 2016 to December 2019 were enrolled and randomly divided into clopidogrel group and ticagrelor group in Ruijin Hospital, and 100 cases in each group. Adenosine diphosphate (ADP) inhibition ratio, maximum amplitude adenosine diphosphate (MAADP) and arachidonic acid (AA) inhibition ratio were tested with thromboelastogram (TEG) within three days after stent implantation, as well as adverse cardiovascular events and bleeding complications were followed up and observed within one year after stent implantation.

Results

ADP inhibition ratio in ticagrelor group was higher than that in clopidogrel group (P<0.05), MAADP in ticagrelor group was lower than that in clopidogrel group (P<0.05). There was no significant difference of AA inhibition ratio, adverse cardiovascular events and bleeding events between two groups (P>0.05).

Conclusion

Ticagrelor was more effective than clopidogrel on platelet inhibition, but their clinical efficacy and safty were similar.

clopidogrel  /  ticagrelor  /  acute coronary syndrome  /  thromboelastogram  /  adenosine diphosphate inhibition ratio  /  maximum amplitude adenosine diphosphate  /  arachidonic acid inhibition ratio  /  adverse cardiovascular event  /  bleeding event
王潜, 陈颖, 左君丽, 钱漪. 氯吡格雷和替格瑞洛对急性冠脉综合征支架术后患者血小板抑制效果、疗效及安全性比较. 世界临床药物, 2022 , 43 (3) : 253 -258 . DOI: 10.13683/j.wph.2022.03.008
Qian WANG, Ying CHEN, Junli ZUO, Yi QIAN. Comparison of platelet inhibitory effect, clinical efficacy and safety of clopidogrel and ticagrelor in patients with acute coronary syndrome undergoing stent implantation[J]. World Clinical Drug, 2022 , 43 (3) : 253 -258 . DOI: 10.13683/j.wph.2022.03.008
Year 2022 volume 43 Issue 3
12
3
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2022.03.008
  • Receive Date:2021-06-24
  • Online Date:2026-11-19
  • Published:2022-03-10
Article Data
Affiliations
History
  • Received:2021-06-24
  • Revised:2022-02-08
Affiliations
    1.Department of Geriatrics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 201801, China
    2.Department of Vascular and Cardiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 201801, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2022.03.008
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT